Bini Mathew

1.6k total citations
23 papers, 1.2k citations indexed

About

Bini Mathew is a scholar working on Pharmacology, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Bini Mathew has authored 23 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 8 papers in Organic Chemistry and 8 papers in Molecular Biology. Recurrent topics in Bini Mathew's work include Inflammatory mediators and NSAID effects (8 papers), Estrogen and related hormone effects (6 papers) and Synthesis and biological activity (5 papers). Bini Mathew is often cited by papers focused on Inflammatory mediators and NSAID effects (8 papers), Estrogen and related hormone effects (6 papers) and Synthesis and biological activity (5 papers). Bini Mathew collaborates with scholars based in United States, United Kingdom and Germany. Bini Mathew's co-authors include Richard R. Schmidt, Vincenzo Cerundolo, Gerd Ritter, Mariolina Salio, Adrian L. Harris, Uzi Gileadi, Jonathan D. Silk, Ian F. Hermans, Dawn Shepherd and Robert C. Reynolds and has published in prestigious journals such as Journal of Clinical Investigation, Nature Immunology and The Journal of Immunology.

In The Last Decade

Bini Mathew

23 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bini Mathew United States 13 838 273 239 183 127 23 1.2k
Latha Pathangey United States 16 444 0.5× 483 1.8× 323 1.4× 136 0.7× 220 1.7× 26 1.1k
Teruyuki Sakai Japan 19 1.1k 1.4× 708 2.6× 218 0.9× 353 1.9× 53 0.4× 31 1.9k
Sang Hsu United States 12 742 0.9× 326 1.2× 232 1.0× 78 0.4× 20 0.2× 13 1.1k
Mathias Rickert United States 10 710 0.8× 306 1.1× 319 1.3× 128 0.7× 19 0.1× 15 1.2k
Eliada Lazoura Australia 11 269 0.3× 423 1.5× 64 0.3× 166 0.9× 28 0.2× 19 764
Sanjay Khandekar United States 7 268 0.3× 396 1.5× 98 0.4× 35 0.2× 66 0.5× 11 683
Xueji Wu China 17 186 0.2× 494 1.8× 123 0.5× 92 0.5× 31 0.2× 32 918
Anna Ericsson Sweden 14 498 0.6× 170 0.6× 154 0.6× 192 1.0× 9 0.1× 26 954
Norman Kairies Germany 7 159 0.2× 607 2.2× 207 0.9× 106 0.6× 42 0.3× 7 874
Peter Öhlschläger Germany 16 363 0.4× 339 1.2× 374 1.6× 80 0.4× 16 0.1× 20 924

Countries citing papers authored by Bini Mathew

Since Specialization
Citations

This map shows the geographic impact of Bini Mathew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bini Mathew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bini Mathew more than expected).

Fields of papers citing papers by Bini Mathew

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bini Mathew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bini Mathew. The network helps show where Bini Mathew may publish in the future.

Co-authorship network of co-authors of Bini Mathew

This figure shows the co-authorship network connecting the top 25 collaborators of Bini Mathew. A scholar is included among the top collaborators of Bini Mathew based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bini Mathew. Bini Mathew is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tinsley, Heather N., Bini Mathew, Yulia Maxuitenko, et al.. (2023). Novel Non-Cyclooxygenase Inhibitory Derivative of Sulindac Inhibits Breast Cancer Cell Growth In Vitro and Reduces Mammary Tumorigenesis in Rats. Cancers. 15(3). 646–646. 5 indexed citations
2.
Mathew, Bini, Ritesh K. Srivastava, Jasim Khan, et al.. (2022). Development of BRD4 inhibitors as anti-inflammatory agents and antidotes for arsenicals. Bioorganic & Medicinal Chemistry Letters. 64. 128696–128696. 5 indexed citations
3.
Traylor, Amie, Bini Mathew, J. Robert Bostwick, et al.. (2022). Identification of Cytoprotective Small-Molecule Inducers of Heme-Oxygenase-1. Antioxidants. 11(10). 1888–1888. 2 indexed citations
4.
Suto, Mark J., et al.. (2020). Identification of Inhibitors of Thrombospondin 1 Activation of TGF-β. ACS Medicinal Chemistry Letters. 11(6). 1130–1136. 15 indexed citations
5.
Mathew, Bini, Shilpa Dutta, Sixue Zhang, et al.. (2020). Structure-activity relationship (SAR) studies of N-(3-methylpyridin-2-yl)-4-(pyridin-2-yl)thiazol-2-amine (SRI-22819) as NF-ҡB activators for the treatment of ALS. European Journal of Medicinal Chemistry. 210. 112952–112952. 7 indexed citations
6.
Mathew, Bini, et al.. (2020). Development of novel small molecules for the treatment of ALS. Bioorganic & Medicinal Chemistry Letters. 30(4). 126950–126950. 8 indexed citations
7.
Gibbons, Garrett S., Afoma C. Umeano, Chenzhong Liao, et al.. (2020). Identification of DOT1L inhibitors by structure-based virtual screening adapted from a nucleoside-focused library. European Journal of Medicinal Chemistry. 189. 112023–112023. 18 indexed citations
8.
Mathew, Bini, Timothy S. Snowden, Michele Connelly, R. Kiplin Guy, & Robert C. Reynolds. (2018). A small diversity library of α-methyl amide analogs of sulindac for probing anticancer structure-activity relationships. Bioorganic & Medicinal Chemistry Letters. 28(12). 2136–2142. 9 indexed citations
9.
Mathew, Bini, Judith V. Hobrath, Michele Connelly, R. Kiplin Guy, & Robert C. Reynolds. (2018). Amine Containing Analogs of Sulindac for Cancer Prevention. Discovery Research Portal (University of Dundee). 12(1). 1–12. 3 indexed citations
10.
Mathew, Bini, Judith V. Hobrath, Wenyan Lü, Yonghe Li, & Robert C. Reynolds. (2017). Synthesis and preliminary assessment of the anticancer and Wnt/β-catenin inhibitory activity of small amide libraries of fenamates and profens. Medicinal Chemistry Research. 26(11). 3038–3045. 18 indexed citations
11.
Mathew, Bini, Judith V. Hobrath, Michele Connelly, R. Kiplin Guy, & Robert C. Reynolds. (2017). Diverse amide analogs of sulindac for cancer treatment and prevention. Bioorganic & Medicinal Chemistry Letters. 27(20). 4614–4621. 22 indexed citations
12.
Mathew, Bini, Judith V. Hobrath, Larry J. Ross, et al.. (2016). Screening and Development of New Inhibitors of FtsZ from M. Tuberculosis. PLoS ONE. 11(10). e0164100–e0164100. 23 indexed citations
13.
Mathew, Bini, Larry J. Ross, & Robert C. Reynolds. (2013). A novel quinoline derivative that inhibits mycobacterial FtsZ. Tuberculosis. 93(4). 398–400. 25 indexed citations
14.
Mathew, Bini, Shefali Srivastava, Larry J. Ross, et al.. (2011). Novel pyridopyrazine and pyrimidothiazine derivatives as FtsZ inhibitors. Bioorganic & Medicinal Chemistry. 19(23). 7120–7128. 40 indexed citations
15.
Piazza, Gary A., Adam B. Keeton, Heather N. Tinsley, et al.. (2010). NSAIDs: Old Drugs Reveal New Anticancer Targets. Pharmaceuticals. 3(5). 1652–1667. 49 indexed citations
16.
Mathew, Bini & Richard R. Schmidt. (2006). Potential sialyltransferase inhibitors based on neuraminyl substitution by hetaryl rings. Carbohydrate Research. 342(3-4). 558–566. 8 indexed citations
17.
Koch, Michael, Dawn Shepherd, Stephan D. Gadola, et al.. (2005). The crystal structure of human CD1d with and without α-galactosylceramide. Nature Immunology. 6(8). 819–826. 324 indexed citations
18.
Silk, Jonathan D., Ian F. Hermans, Uzi Gileadi, et al.. (2004). Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell–mediated immunotherapy. Journal of Clinical Investigation. 114(12). 1800–1811. 14 indexed citations
19.
Silk, Jonathan D., Ian F. Hermans, Uzi Gileadi, et al.. (2004). Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell–mediated immunotherapy. Journal of Clinical Investigation. 114(12). 1800–1811. 142 indexed citations
20.
Hermans, Ian F., Jonathan D. Silk, Uzi Gileadi, et al.. (2003). NKT Cells Enhance CD4+ and CD8+ T Cell Responses to Soluble Antigen In Vivo through Direct Interaction with Dendritic Cells. The Journal of Immunology. 171(10). 5140–5147. 383 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Latha Pathangey Breakdown of academic impact, for papers by Teruyuki Sakai Breakdown of academic impact, for papers by Sang Hsu Breakdown of academic impact, for papers by Mathias Rickert Breakdown of academic impact, for papers by Eliada Lazoura Breakdown of academic impact, for papers by Sanjay Khandekar Breakdown of academic impact, for papers by Xueji Wu Breakdown of academic impact, for papers by Anna Ericsson Breakdown of academic impact, for papers by Norman Kairies Breakdown of academic impact, for papers by Peter Öhlschläger
Rankless by CCL
2026